GH
The startup has developed a non-invasive wearable device that continuously monitors and manages blood sugar levels without the need for pills or injections. Its technology demonstrates significant anti-diabetic effects in animal models, enabling patients to lower blood sugar and reverse insulin resistance without causing weight gain or hypoglycemia.
Updated 2 months ago
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a non-invasive wearable device that continuously monitors and manages blood sugar levels without the need for pills or injections. Its technology demonstrates significant anti-diabetic effects in animal models, enabling patients to lower blood sugar and reverse insulin resistance without causing weight gain or hypoglycemia.